Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Related structures:
AlphaFold database: A4HBG4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.559 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.534 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.405 |
CLV_PCSK_PC1ET2_1 | 123 | 125 | PF00082 | 0.255 |
CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.464 |
CLV_PCSK_SKI1_1 | 292 | 296 | PF00082 | 0.412 |
DEG_SCF_FBW7_2 | 22 | 27 | PF00400 | 0.358 |
DEG_SPOP_SBC_1 | 80 | 84 | PF00917 | 0.339 |
DOC_MAPK_gen_1 | 194 | 202 | PF00069 | 0.381 |
DOC_MAPK_HePTP_8 | 311 | 323 | PF00069 | 0.455 |
DOC_MAPK_MEF2A_6 | 314 | 323 | PF00069 | 0.461 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.432 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.284 |
DOC_USP7_MATH_1 | 246 | 250 | PF00917 | 0.346 |
DOC_USP7_MATH_1 | 283 | 287 | PF00917 | 0.379 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.385 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.408 |
DOC_WW_Pin1_4 | 20 | 25 | PF00397 | 0.329 |
DOC_WW_Pin1_4 | 219 | 224 | PF00397 | 0.473 |
DOC_WW_Pin1_4 | 272 | 277 | PF00397 | 0.444 |
DOC_WW_Pin1_4 | 295 | 300 | PF00397 | 0.459 |
LIG_14-3-3_CanoR_1 | 124 | 133 | PF00244 | 0.370 |
LIG_14-3-3_CanoR_1 | 164 | 171 | PF00244 | 0.326 |
LIG_14-3-3_CanoR_1 | 256 | 260 | PF00244 | 0.389 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.469 |
LIG_BRCT_BRCA1_1 | 166 | 170 | PF00533 | 0.306 |
LIG_CtBP_PxDLS_1 | 299 | 303 | PF00389 | 0.461 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.502 |
LIG_FHA_1 | 138 | 144 | PF00498 | 0.377 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.439 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.366 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.300 |
LIG_FHA_1 | 234 | 240 | PF00498 | 0.402 |
LIG_FHA_1 | 252 | 258 | PF00498 | 0.327 |
LIG_FHA_1 | 264 | 270 | PF00498 | 0.327 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.298 |
LIG_LIR_Apic_2 | 178 | 184 | PF02991 | 0.385 |
LIG_LIR_Gen_1 | 57 | 66 | PF02991 | 0.350 |
LIG_LIR_Gen_1 | 74 | 85 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 57 | 61 | PF02991 | 0.423 |
LIG_LIR_Nem_3 | 74 | 80 | PF02991 | 0.473 |
LIG_Pex14_2 | 166 | 170 | PF04695 | 0.314 |
LIG_Rb_pABgroove_1 | 131 | 139 | PF01858 | 0.464 |
LIG_SH2_STAP1 | 137 | 141 | PF00017 | 0.469 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.313 |
LIG_SH3_3 | 217 | 223 | PF00018 | 0.463 |
LIG_SH3_3 | 56 | 62 | PF00018 | 0.377 |
LIG_SUMO_SIM_anti_2 | 138 | 145 | PF11976 | 0.270 |
LIG_SUMO_SIM_par_1 | 114 | 119 | PF11976 | 0.378 |
LIG_SUMO_SIM_par_1 | 138 | 145 | PF11976 | 0.249 |
LIG_SUMO_SIM_par_1 | 215 | 222 | PF11976 | 0.481 |
LIG_SUMO_SIM_par_1 | 9 | 14 | PF11976 | 0.410 |
LIG_TRAF2_1 | 106 | 109 | PF00917 | 0.398 |
LIG_TRAF2_2 | 184 | 189 | PF00917 | 0.321 |
MOD_CDK_SPK_2 | 219 | 224 | PF00069 | 0.483 |
MOD_CDK_SPxxK_3 | 116 | 123 | PF00069 | 0.447 |
MOD_CK1_1 | 139 | 145 | PF00069 | 0.466 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.349 |
MOD_CK1_1 | 222 | 228 | PF00069 | 0.480 |
MOD_CK1_1 | 275 | 281 | PF00069 | 0.421 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.228 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.260 |
MOD_Cter_Amidation | 121 | 124 | PF01082 | 0.260 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.474 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.285 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.294 |
MOD_GlcNHglycan | 212 | 215 | PF01048 | 0.417 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.297 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.404 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.382 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.397 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.305 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.474 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.343 |
MOD_N-GLC_1 | 154 | 159 | PF02516 | 0.442 |
MOD_N-GLC_1 | 300 | 305 | PF02516 | 0.432 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.320 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.370 |
MOD_NEK2_1 | 300 | 305 | PF00069 | 0.371 |
MOD_NEK2_1 | 319 | 324 | PF00069 | 0.358 |
MOD_NEK2_1 | 46 | 51 | PF00069 | 0.399 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.337 |
MOD_PIKK_1 | 11 | 17 | PF00454 | 0.486 |
MOD_PIKK_1 | 142 | 148 | PF00454 | 0.339 |
MOD_PIKK_1 | 241 | 247 | PF00454 | 0.579 |
MOD_PKA_1 | 101 | 107 | PF00069 | 0.264 |
MOD_PKA_2 | 101 | 107 | PF00069 | 0.424 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.304 |
MOD_PKA_2 | 255 | 261 | PF00069 | 0.271 |
MOD_Plk_1 | 137 | 143 | PF00069 | 0.348 |
MOD_Plk_1 | 300 | 306 | PF00069 | 0.444 |
MOD_Plk_1 | 96 | 102 | PF00069 | 0.486 |
MOD_Plk_4 | 139 | 145 | PF00069 | 0.435 |
MOD_Plk_4 | 275 | 281 | PF00069 | 0.440 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.382 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.403 |
MOD_ProDKin_1 | 20 | 26 | PF00069 | 0.328 |
MOD_ProDKin_1 | 219 | 225 | PF00069 | 0.486 |
MOD_ProDKin_1 | 272 | 278 | PF00069 | 0.439 |
MOD_ProDKin_1 | 295 | 301 | PF00069 | 0.453 |
TRG_ER_diArg_1 | 100 | 102 | PF00400 | 0.546 |
TRG_Pf-PMV_PEXEL_1 | 169 | 173 | PF00026 | 0.462 |
TRG_Pf-PMV_PEXEL_1 | 238 | 242 | PF00026 | 0.526 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IGS3 | Leptomonas seymouri | 58% | 100% |
A0A0S4IPM9 | Bodo saltans | 38% | 96% |
A0A0S4IXK3 | Bodo saltans | 27% | 87% |
A0A0S4JA66 | Bodo saltans | 24% | 99% |
A0A1X0PB94 | Trypanosomatidae | 36% | 96% |
A0A3R7RJK1 | Trypanosoma rangeli | 35% | 97% |
A0A3S7X8N9 | Leishmania donovani | 74% | 100% |
A4IAL0 | Leishmania infantum | 74% | 100% |
C9ZLN0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 98% |
E9B5N5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 100% |
Q4Q283 | Leishmania major | 74% | 100% |
V5BRD1 | Trypanosoma cruzi | 35% | 97% |